Search research articles
Contact Us
Filters
Showing results (201-210 of 421) with videos related to
Page
of 43
Sort By:
Histopathology
|
April 30, 2019
The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
Daniel M Berney, Luis Beltran, Holly Sandu, et al.
NPJ Digital Medicine
|
November 28, 2023
An optimization framework to guide the choice of thresholds for risk-based cancer screening
Adam R Brentnall, Emma C Atakpa, Harry Hill, et al.
International Journal of Cancer
|
August 29, 2007
The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective
Paolo Giorgi-Rossi, Nereo Segnan, Marco Zappa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2021
Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma <i>in situ</i>: Results from the UK/ANZ DCIS Trial
Mangesh A Thorat, Pauline M Levey, J Louise Jones, et al.
Oncotarget
|
October 7, 2016
A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors
Amar S Ahmad, Nataša Vasiljević, Paul Carter, et al.
British Journal of Cancer
|
April 22, 2016
Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
Daniel M Berney, Luis Beltran, Gabrielle Fisher, et al.
Journal of the National Cancer Institute
|
July 13, 2016
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
Richard Buus, Ivana Sestak, Ralf Kronenwett, et al.
International Journal of Cancer
|
May 17, 2017
Role of quantitative p16<sup>INK4A</sup> mRNA assay and digital reading of p16<sup>INK4A</sup> immunostained sections in diagnosis of cervical intraepithelial neoplasia
Nataša Vasiljević, Paul D Carter, Caroline Reuter, et al.
JAMA Oncology
|
June 28, 2017
Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing
Jack Cuzick, Orrin Myers, Ji-Hyun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial
Mangesh A Thorat, Pauline M Levey, J Louise Jones, et al.
Page
of 43
Search research articles
Search
Showing results (201-210 of 421) with videos related to
Sort By:
Page
of 43
Histopathology
|
April 30, 2019
The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
Daniel M Berney, Luis Beltran, Holly Sandu, et al.
NPJ Digital Medicine
|
November 28, 2023
An optimization framework to guide the choice of thresholds for risk-based cancer screening
Adam R Brentnall, Emma C Atakpa, Harry Hill, et al.
International Journal of Cancer
|
August 29, 2007
The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective
Paolo Giorgi-Rossi, Nereo Segnan, Marco Zappa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2021
Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma <i>in situ</i>: Results from the UK/ANZ DCIS Trial
Mangesh A Thorat, Pauline M Levey, J Louise Jones, et al.
Oncotarget
|
October 7, 2016
A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors
Amar S Ahmad, Nataša Vasiljević, Paul Carter, et al.
British Journal of Cancer
|
April 22, 2016
Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
Daniel M Berney, Luis Beltran, Gabrielle Fisher, et al.
Journal of the National Cancer Institute
|
July 13, 2016
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
Richard Buus, Ivana Sestak, Ralf Kronenwett, et al.
International Journal of Cancer
|
May 17, 2017
Role of quantitative p16<sup>INK4A</sup> mRNA assay and digital reading of p16<sup>INK4A</sup> immunostained sections in diagnosis of cervical intraepithelial neoplasia
Nataša Vasiljević, Paul D Carter, Caroline Reuter, et al.
JAMA Oncology
|
June 28, 2017
Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing
Jack Cuzick, Orrin Myers, Ji-Hyun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial
Mangesh A Thorat, Pauline M Levey, J Louise Jones, et al.
Page
of 43